Ruxolitinib in Patients With Chronic Active Epstein-Barr Virus Infection: A Retrospective, Single-Center Study

Background: Chronic active Epstein-Barr virus (CAEBV) infection is one of the EBV-positive T- or NK-cell lymphoproliferative diseases. There is no safe and effective treatment currently and the only proven curable therapy is allogeneic hematopoietic stem cell transplantation (allo-HSCT). The JAK1/2...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yue, Wang, Jingshi, Wang, Yini, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450490/
https://www.ncbi.nlm.nih.gov/pubmed/34552486
http://dx.doi.org/10.3389/fphar.2021.710400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450490/
https://www.ncbi.nlm.nih.gov/pubmed/34552486
http://dx.doi.org/10.3389/fphar.2021.710400

Ejemplares similares